<li>alfuzosin<p>alfuzosin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>almotriptan<p>ondansetron, almotriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>amiodarone<p>amiodarone and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>amitriptyline<p>amitriptyline and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, amitriptyline.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>amoxapine<p>amoxapine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, amoxapine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>arformoterol<p>arformoterol and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>arsenic trioxide<p>arsenic trioxide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>artemether/lumefantrine<p>artemether/lumefantrine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>asenapine<p>asenapine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>azithromycin<p>azithromycin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>chlorpromazine<p>chlorpromazine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>ciprofloxacin<p>ciprofloxacin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>cisapride<p>cisapride and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>citalopram<p>citalopram and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, citalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>clarithromycin<p>clarithromycin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Potential for increased ondansetron levels.</p></li><li>clomipramine<p>clomipramine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, clomipramine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>clozapine<p>clozapine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>crizotinib<p>crizotinib and ondansetron both decrease  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>dasatinib<p>dasatinib and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>degarelix<p>degarelix and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>desipramine<p>desipramine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, desipramine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>desvenlafaxine<p>ondansetron, desvenlafaxine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>disopyramide<p>disopyramide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>dofetilide<p>dofetilide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>dolasetron<p>dolasetron and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>doxepin<p>ondansetron, doxepin.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>droperidol<p>droperidol and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>duloxetine<p>ondansetron, duloxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>eletriptan<p>ondansetron, eletriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>erythromycin base<p>erythromycin base and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>erythromycin ethylsuccinate<p>erythromycin ethylsuccinate and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>erythromycin lactobionate<p>erythromycin lactobionate and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>erythromycin stearate<p>erythromycin stearate and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>escitalopram<p>escitalopram and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, escitalopram.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>ezogabine<p>ezogabine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>flecainide<p>flecainide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>fluconazole<p>fluconazole and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Combination may increase ondansetron levels.</p></li><li>fluoxetine<p>fluoxetine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, fluoxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>fluphenazine<p>fluphenazine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>fluvoxamine<p>ondansetron, fluvoxamine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>formoterol<p>formoterol and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>foscarnet<p>foscarnet and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>frovatriptan<p>ondansetron, frovatriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>gemifloxacin<p>gemifloxacin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>haloperidol<p>haloperidol and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>ibutilide<p>ibutilide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>idelalisib<p>idelalisib will increase the level or effect of ondansetron by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Idelalisib is a strong CYP3A inhibitor; avoid coadministration with sensitive CYP3A substrates</p></li><li>iloperidone<p>iloperidone and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>imipramine<p>ondansetron, imipramine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>indacaterol, inhaled<p>indacaterol, inhaled, ondansetron. QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>indapamide<p>indapamide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>isocarboxazid<p>ondansetron, isocarboxazid.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>isradipine<p>isradipine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>ivacaftor<p>ivacaftor increases levels of ondansetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Ivacaftor and its M1 metabolite has the potential to inhibit CYP3A4, may significantly increase systemic exposure to 3A4 substrates.<span><br><br></span>ivacaftor increases levels of ondansetron by P-glycoprotein (MDR1) efflux transporter. Avoid or Use Alternate Drug. Ivacaftor and its M1 metabolite has the potential to inhibit P-gp, may significantly increase systemic exposure to P-gp substrates.</p></li><li>lapatinib<p>lapatinib and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Potential for increased ondansetron levels.</p></li><li>levofloxacin<p>levofloxacin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>levomilnacipran<p>ondansetron, levomilnacipran.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>lumefantrine<p>lumefantrine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>maprotiline<p>maprotiline and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>mefloquine<p>mefloquine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>methadone<p>methadone and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>milnacipran<p>ondansetron, milnacipran.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>moxifloxacin<p>moxifloxacin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>naratriptan<p>ondansetron, naratriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>nilotinib<p>nilotinib and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Potential for increased ondansetron levels.</p></li><li>nortriptyline<p>nortriptyline and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, nortriptyline.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>octreotide<p>octreotide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>ofloxacin<p>ofloxacin and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>olanzapine<p>olanzapine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>paliperidone<p>paliperidone and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>paroxetine<p>ondansetron, paroxetine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>pazopanib<p>pazopanib and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>pentamidine<p>pentamidine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>perphenazine<p>perphenazine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>phenelzine<p>ondansetron, phenelzine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>pimozide<p>pimozide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>posaconazole<p>posaconazole and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Potential for increased ondansetron levels.</p></li><li>procainamide<p>procainamide and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>propafenone<p>propafenone and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>protriptyline<p>protriptyline and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, protriptyline.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>quetiapine<p>quetiapine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>quinidine<p>quinidine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>quinine<p>quinine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>ranolazine<p>ranolazine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>rasagiline<p>ondansetron, rasagiline.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>ribociclib<p>ribociclib and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.</p></li><li>risperidone<p>ondansetron and risperidone both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>rizatriptan<p>ondansetron, rizatriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>romidepsin<p>ondansetron and romidepsin both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>saquinavir<p>ondansetron and saquinavir both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>selegiline<p>ondansetron, selegiline.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>selegiline transdermal<p>ondansetron, selegiline transdermal.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sertraline<p>ondansetron and sertraline both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, sertraline.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>solifenacin<p>ondansetron and solifenacin both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>sotalol<p>ondansetron and sotalol both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>sumatriptan<p>ondansetron, sumatriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sumatriptan intranasal<p>ondansetron, sumatriptan intranasal.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sumatriptan transdermal<p>ondansetron, sumatriptan transdermal.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>sunitinib<p>ondansetron and sunitinib both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>tacrolimus<p>ondansetron and tacrolimus both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>tedizolid<p>tedizolid, ondansetron.
Either increases effects of the other by Mechanism: pharmacodynamic synergism. Avoid or Use Alternate Drug. both increase serotonin levels; increased risk of serotonin syndrome.</p></li><li>telaprevir<p>ondansetron and telaprevir both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>telavancin<p>ondansetron and telavancin both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>telithromycin<p>ondansetron and telithromycin both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>thioridazine<p>thioridazine and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>thiothixene<p>ondansetron and thiothixene both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>toremifene<p>ondansetron and toremifene both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>tranylcypromine<p>ondansetron, tranylcypromine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>trimipramine<p>ondansetron and trimipramine both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.<span><br><br></span>ondansetron, trimipramine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>umeclidinium bromide/vilanterol inhaled<p>ondansetron increases toxicity of umeclidinium bromide/vilanterol inhaled by QTc interval. Avoid or Use Alternate Drug. Exercise extreme caution when vilanterol coadministered with drugs that prolong QTc interval; adrenergic agonist effects on the cardiovascular system may be potentiated.</p></li><li>vandetanib<p>vandetanib and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>vardenafil<p>ondansetron and vardenafil both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>vemurafenib<p>ondansetron and vemurafenib both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Alterations in ondansetron concentrations may occur with concomitant use.</p></li><li>venlafaxine<p>ondansetron, venlafaxine.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li><li>vilanterol/fluticasone furoate inhaled<p>ondansetron increases toxicity of vilanterol/fluticasone furoate inhaled by QTc interval. Avoid or Use Alternate Drug. Exercise extreme caution when vilanterol coadministered with drugs that prolong QTc interval; adrenergic agonist effects on the cardiovascular system may be potentiated.</p></li><li>voriconazole<p>ondansetron and voriconazole both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias. Potential for increased ondansetron levels.</p></li><li>vorinostat<p>ondansetron and vorinostat both increase  QTc interval. Avoid or Use Alternate Drug. Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>ziprasidone<p>ziprasidone and ondansetron both increase  QTc interval. Avoid or Use Alternate Drug.  Avoid with congenital long QT syndrome; ECG monitoring recommended with concomitant medications that prolong QT interval, electrolyte abnormalities, CHF, or bradyarrhythmias.</p></li><li>zolmitriptan<p>ondansetron, zolmitriptan.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug.</p></li>